Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

NCT00429026 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

40

Enrollment

OTHER

Sponsor class

Stopped Slow accrual, study terminated.

Conditions

Renal Cell Cancer

Interventions

DRUG: Fludarabine
DRUG: Melphalan
DRUG: Cyclophosphamide
PROCEDURE: Stem Cell Transplant

Sponsor

M.D. Anderson Cancer Center